Fundraising Fox
Neil Exter
InvestorPartner at Third Rock Ventures
East Coast
Writes $100K – $5M checks · typically $1.5M
Find your path to Neil
Sign up to see every warm intro you have to Neil
- Paths you didn't know you had: your email and LinkedIn already hold routes to Neil. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Neil Exter is a retired partner at Third Rock Ventures, which he joined in 2007, where he concentrated on the formation, development and strategy of new companies. He brings more than 30 years of operating, business development and strategy experience spanning emerging and established biotechnology and technology companies. He trained as an electrical engineer, earning degrees from Cornell and Stanford before completing an MBA at Harvard Business School.
Contact· published on Neil's own website
Beyond investing
- Education
- Earned a B.S. in Electrical Engineering from Cornell University. Earned an M.S. in Electrical Engineering from Stanford University. Holds an MBA from Harvard Business School.
From Neil's own website — common ground for a warm intro.
Deals · 7
Cedilla Therapeutics, Inc.Board seat
via Third Rock Ventures · filed Oct 2021 · $82.6M raise
Goldfinch BioPharmaBoard seat
via Third Rock Ventures · filed Jul 2020
Revolution MedicinesBoard seat
via Third Rock Ventures · filed Nov 2019 · $100.3M raise
Pliant TherapeuticsBoard seat
via Third Rock Ventures · filed Jul 2018 · $62.1M raise
Element ScienceBoard seat
via Third Rock Ventures · filed Aug 2016 · $25M raise
Rhythm PharmaceuticalsBoard seat
via Third Rock Ventures · filed Dec 2015 · $40M raise
CytomX TherapeuticsBoard seat
via Third Rock Ventures · filed Jan 2015 · $30M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Decibel Therapeutics
Investor
CibiemLotus Tissue RepairSoffio MedicalThrive Earlier Detection
Sources: SEC Form D filings · curated public sources.
Colleagues at Third Rock Ventures
Frequently asked questions
- Who is Neil Exter?
- Neil Exter is a retired partner at Third Rock Ventures, which he joined in 2007, where he concentrated on the formation, development and strategy of new companies. He brings more than 30 years of operating, business development and strategy experience spanning emerging and established biotechnology and technology companies. He trained as an electrical engineer, earning degrees from Cornell and Stanford before completing an MBA at Harvard Business School.
- Where does Neil Exter work?
- Neil Exter is Partner at Third Rock Ventures.
- What check size does Neil Exter write?
- Neil Exter typically writes checks of $100K – $5M.
- What boards does Neil Exter sit on?
- Neil Exter holds tracked board seats at Cedilla Therapeutics, Inc., CytomX Therapeutics, Decibel Therapeutics, Element Science, Goldfinch BioPharma, Pliant Therapeutics, Revolution Medicines, Rhythm Pharmaceuticals.
- What companies has Neil Exter invested in?
- Investments tracked here include Cibiem, CytomX Therapeutics, Lotus Tissue Repair, Soffio Medical, Thrive Earlier Detection.
About this profile. Compiled from public sources — Third Rock Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights